OZENOXACIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C21H21N3O3
Molecular Weight	363.4097
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of OZENOXACIN

Structure Search

SMILES

CNC1=C(C)C=C(C=N1)C2=C(C)C3=C(C=C2)C(=O)C(=CN3C4CC4)C(O)=O

InChI

InChIKey=XPIJWUTXQAGSLK-UHFFFAOYSA-N

InChI=1S/C21H21N3O3/c1-11-8-13(9-23-20(11)22-3)15-6-7-16-18(12(15)2)24(14-4-5-14)10-17(19(16)25)21(26)27/h6-10,14H,4-5H2,1-3H3,(H,22,23)(H,26,27)

HIDE SMILES / InChI

Molecular Formula	C21H21N3O3
Molecular Weight	363.4097
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:12:34 UTC 2023` Edited by `admin` on `Fri Dec 15 16:12:34 UTC 2023`
Record UNII	V0LH498RFO
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

OZENOXACIN

Official Name

English

OZENOXACIN [JAN]

Common Name

English

XEPI

Brand Name

English

OZENOXACIN [ORANGE BOOK]

Common Name

English

1-CYCLOPROPYL-8-METHYL-7-(5-METHYL-6-(METHYLAMINO)PYRIDIN-3-YL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID

Systematic Name

English

OZENOXACIN [MI]

Common Name

English

Ozenoxacin [WHO-DD]

Common Name

English

3-QUINOLINECARBOXYLIC ACID, 1-CYCLOPROPYL-1,4-DIHYDRO-8-METHYL-7-(5-METHYL-6-(METHYLAMINO)-3-PYRIDINYL)-4-OXO-

Systematic Name

English

OZENOXACIN [USAN]

Common Name

English

GF-001001-00

Code

English

T-3912

Code

English

ozenoxacin [INN]

Common Name

English

Classification Tree Code System Code

WHO-ATC

D06AX14

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

NDF-RT

N0000175937

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

NCI_THESAURUS

C795

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

Code System Code Type Description

FDA UNII

V0LH498RFO

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

DAILYMED

V0LH498RFO

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

DRUG BANK

DB12924

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

WIKIPEDIA

Ozenoxacin

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

SMS_ID

100000172897

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

CAS

245765-41-7

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

DRUG CENTRAL

5058

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

NCI_THESAURUS

C90935

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

LACTMED

Ozenoxacin

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

USAN

HI-129

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

EPA CompTox

DTXSID00947446

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

MERCK INDEX

m11943

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

RXCUI

1994739

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

PUBCHEM

9863827

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

INN

8788

Created by admin on Fri Dec 15 16:12:34 UTC 2023 , Edited by admin on Fri Dec 15 16:12:34 UTC 2023

PRIMARY

Related Record Type Details


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> INHIBITOR

Comments:

In vitro, ozenoxacin caused mild inhibition of CYP3A4 and CYP2C9 at high concentrations (≥100 μM).


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> INHIBITOR

Comments:

In vitro, ozenoxacin caused mild inhibition of CYP3A4 and CYP2C9 at high concentrations (≥100 μM).


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					O478WX4004

STAPHYLOCOCCUS AUREUS

TARGET -> INHIBITOR

Amount:


					LJ2LP0YL98

STREPTOCOCCUS PYOGENES

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					V0LH498RFO

ACTIVE MOIETY